Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection

  1. Flora Mikaeloff  Is a corresponding author
  2. Marco Gelpi
  3. Rui Benfeitas
  4. Andreas D Knudsen
  5.  Beate Vestad
  6.  Julie Høgh
  7. Johannes R Hov
  8. Thomas Benfield
  9. Daniel Murray
  10. Christian G Giske
  11. Adil Mardinoglu
  12. Marius Trøseid
  13. Susanne D Nielsen
  14. Ujjwal Neogi  Is a corresponding author
  1. Karolinska Institute, Sweden
  2. Rigshospitalet, Denmark
  3. Oslo University Hospital, Norway
  4. Copenhagen University Hospital, Denmark
  5. King's College London, United Kingdom

Abstract

Multiomics technologies improve the biological understanding of health status in people living with HIV on antiretroviral therapy (PLWH). Still, a systematic and in-depth characterization of metabolic risk profile during successful long-term treatment is lacking. Here, we used multi-omics (plasma lipidomic, metabolomic, and fecal 16S microbiome) data-driven stratification and characterization to identify the metabolic at-risk profile within PLWH. Through network analysis and similarity network fusion (SNF), we identified three groups of PLWH (SNF-1 to 3): healthy (HC)-like (SNF-1), mild at-risk (SNF-3), and severe at-risk (SNF-2). The PLWH in the SNF-2 (45%) had a severe at-risk metabolic profile with increased visceral adipose tissue, BMI, higher incidence of metabolic syndrome (MetS), and increased di- and triglycerides despite having higher CD4+ T-cell counts than the other two clusters. However, the HC-like and the severe at-risk group had a similar metabolic profile differing from HIV-negative controls (HNC), with dysregulation of amino acid metabolism. At the microbiome profile, the HC-like group had a lower α-diversity, a lower proportion of men having sex with men (MSM) and was enriched in Bacteroides. In contrast, in at-risk groups, there was an increase in Prevotella, with a high proportion of MSM, which could potentially lead to higher systemic inflammation and increased cardiometabolic risk profile. The multi-omics integrative analysis also revealed a complex microbial interplay of the microbiome-derived metabolites in PLWH. Those severely at-risk clusters may benefit from personalized medicine and lifestyle intervention to improve their dysregulated metabolic traits, aiming to achieve healthier aging.

Data availability

All of the data generated or analyzed during this study are included in this published article and/or the supplementary materials. Created datasets and code are publicly available. The metabolomics and lipidomics data are available from https://doi.org/10.6084/m9.figshare.14356754.v1 and https://doi.org/10.6084/m9.figshare.14509452.v1. All the codes are available at github: https://github.com/neogilab/HIV_multiomics

Article and author information

Author details

  1. Flora Mikaeloff

    Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
    For correspondence
    flora.mikaeloff@ki.se
    Competing interests
    The authors declare that no competing interests exist.
  2. Marco Gelpi

    Rigshospitalet, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  3. Rui Benfeitas

    Department of Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  4. Andreas D Knudsen

    Rigshospitalet, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  5.  Beate Vestad

    Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  6.  Julie Høgh

    Rigshospitalet, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  7. Johannes R Hov

    Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  8. Thomas Benfield

    Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0698-9385
  9. Daniel Murray

    Rigshospitalet, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  10. Christian G Giske

    Department of Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  11. Adil Mardinoglu

    Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Marius Trøseid

    Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  13. Susanne D Nielsen

    Rigshospitalet, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  14. Ujjwal Neogi

    Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
    For correspondence
    ujjwal.neogi@ki.se
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0844-3338

Funding

Vetenskapsrådet (2017-01330,2018-06156,2021-01756)

  • Ujjwal Neogi

Novo Nordisk

  • Susanne D Nielsen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Ethical approval was obtained by the Regional Ethics Committee of Copenhagen (COCOMO: H-15017350) and Etikprövningsmyndigheten, Sweden (Dnr: 2022-01353-01). Informed consent was obtained from all participants and delinked before analysis.

Copyright

© 2023, Mikaeloff et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,667
    views
  • 254
    downloads
  • 12
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Flora Mikaeloff
  2. Marco Gelpi
  3. Rui Benfeitas
  4. Andreas D Knudsen
  5.  Beate Vestad
  6.  Julie Høgh
  7. Johannes R Hov
  8. Thomas Benfield
  9. Daniel Murray
  10. Christian G Giske
  11. Adil Mardinoglu
  12. Marius Trøseid
  13. Susanne D Nielsen
  14. Ujjwal Neogi
(2023)
Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
eLife 12:e82785.
https://doi.org/10.7554/eLife.82785

Share this article

https://doi.org/10.7554/eLife.82785

Further reading

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    A Sofia F Oliveira, Fiona L Kearns ... Adrian J Mulholland
    Short Report

    The spike protein is essential to the SARS-CoV-2 virus life cycle, facilitating virus entry and mediating viral-host membrane fusion. The spike contains a fatty acid (FA) binding site between every two neighbouring receptor-binding domains. This site is coupled to key regions in the protein, but the impact of glycans on these allosteric effects has not been investigated. Using dynamical nonequilibrium molecular dynamics (D-NEMD) simulations, we explore the allosteric effects of the FA site in the fully glycosylated spike of the SARS-CoV-2 ancestral variant. Our results identify the allosteric networks connecting the FA site to functionally important regions in the protein, including the receptor-binding motif, an antigenic supersite in the N-terminal domain, the fusion peptide region, and another allosteric site known to bind heme and biliverdin. The networks identified here highlight the complexity of the allosteric modulation in this protein and reveal a striking and unexpected link between different allosteric sites. Comparison of the FA site connections from D-NEMD in the glycosylated and non-glycosylated spike revealed that glycans do not qualitatively change the internal allosteric pathways but can facilitate the transmission of the structural changes within and between subunits.

    1. Computational and Systems Biology
    George N Bendzunas, Dominic P Byrne ... Natarajan Kannan
    Research Article

    In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.